{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T03:10:21Z","timestamp":1780629021617,"version":"3.54.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T00:00:00Z","timestamp":1755129600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T00:00:00Z","timestamp":1755129600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>This study aims to explore the risk associated with the Tumour Necrosis Factor-Alpha (TNF\u03b1)-308 G\/A (rs1800629) gene polymorphism in relation to Childhood Nephrotic Syndrome (NS). The primary goal of the meta-analysis was to investigate the relationship between Nephrotic Syndrome and the TNF\u03b1 308 G\/A [rs1800629] polymorphism of the cytokine gene. We conducted a systematic search across electronic databases like PubMed and Google Scholar to collect data from five distinct case-control studies focused on the <jats:italic>TNF<\/jats:italic>\u03b1 308 G\/A gene variant, covering the period from 2010 to 2022. By aggregating allele and genotype frequencies from these studies, we computed the 95% confidence interval of odds ratio [OR] to assess the strength of the association. To evaluate heterogeneity and potential publication bias in the selected studies, Stats Direct software was employed. The sample size encompassed 1,560 individuals, including 628 cases and 932 controls from five separate case-control studies. The <jats:italic>TNF<\/jats:italic>\u03b1 allele-A displayed significant heterogeneity [I\u00b2=80%, 95% CI] when compared to the G allele, and a statistically significant pooled OR of 2.32 [<jats:italic>P<\/jats:italic>\u2009=\u20090.0056*] was observed. In the overall analysis, no significance association was found in the dominant model [<jats:italic>P<\/jats:italic>\u2009=\u20090.068], but a significant association was detected in the recessive model [<jats:italic>P<\/jats:italic>\u2009=\u20090.0096*]. Consistent findings were observed in the co-dominant model, where both AA vs. GG [<jats:italic>P<\/jats:italic>\u2009=\u20090.0075*] and GA vs. GG [<jats:italic>P<\/jats:italic>\u2009=\u20090.0219*] showed significant associations. These results suggest a potential increase in the risk of the disease associated with the polymorphism of <jats:italic>TNF<\/jats:italic>\u03b1 308 G\/A. The small number of studies, high heterogeneity (I\u00b2 = 80%), and limited ethnic diversity may affect the robustness and generalizability of findings. Additionally, language bias and lack of confounder adjustment limit interpretability. The <jats:italic>TNF<\/jats:italic>\u03b1 308 G\/A polymorphism was identified as being associated with the risk of developing childhood NS.<\/jats:p>\n          <jats:p>Registration: Registered in PROSPERO with ID: CRD420251083425.<\/jats:p>","DOI":"10.1038\/s41598-025-15387-w","type":"journal-article","created":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T05:51:08Z","timestamp":1755150668000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Impact of tumor necrosis factor-alpha gene variant in pediatric nephrotic syndrome: a meta-analysis"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3795-5930","authenticated-orcid":false,"given":"Yogalakshmi","family":"Venkatachalapathy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-2824-1469","authenticated-orcid":false,"given":"Praveenkumar Kochuthakidiyel","family":"Suresh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5041-3925","authenticated-orcid":false,"given":"Thendral Hepsibha","family":"Balraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2827-8680","authenticated-orcid":false,"given":"Vettriselvi","family":"Venkatesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0734-1126","authenticated-orcid":false,"given":"Sangeetha","family":"Geminiganesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indira","family":"Bhagam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6760-785X","authenticated-orcid":false,"given":"C. D. Mohana","family":"Priya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,14]]},"reference":[{"issue":"12","key":"15387_CR1","first-page":"2299","volume":"31","author":"C Dossier","year":"2016","unstructured":"Dossier, C. et al. Epidemiology of idiopathic nephrotic syndrome in children: endemic or epidemic? Pediatricnephrology 31 (12), 2299\u20132308 (2016).","journal-title":"Pediatricnephrology"},{"key":"15387_CR2","doi-asserted-by":"crossref","unstructured":"Bagga, A. Revised guidelines for management of steroid-sensitive nephrotic syndrome. Indian J. Nephrol. 18(1), 31  (2008). https:\/\/mc04.manuscriptcentral.com\/jbn-scielo (Brazilian Journal of Nephrology).","DOI":"10.4103\/0971-4065.41289"},{"key":"15387_CR3","doi-asserted-by":"crossref","unstructured":"Zhang, A. & Huang, S. Progress in pathogenesis of proteinuria. Int. J. Nephrol. 2012 (2012).","DOI":"10.1155\/2012\/314251"},{"issue":"9","key":"15387_CR4","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s00467-002-0929-8","volume":"17","author":"J Zachwieja","year":"2002","unstructured":"Zachwieja, J. et al. Intracellular cytokines of peripheral blood lymphocytes in nephrotic syndrome. Pediatr. Nephrol. 17 (9), 733\u2013740 (2002).","journal-title":"Pediatr. Nephrol."},{"key":"15387_CR5","doi-asserted-by":"crossref","unstructured":"Lama, G. et al. T lymphocyte populations and cytokines in childhood nephrotic syndrome. Am. J. Kidney Dis. 39(5), 958\u2009\u2013\u200965  (2002).","DOI":"10.1053\/ajkd.2002.32769"},{"key":"15387_CR6","doi-asserted-by":"crossref","unstructured":"Fodor, P., Sait\u00faa, M. T., Rodriguez, E., Gonz\u00e1lez, B. & Schlesinger, L. T-cell dysfunction in minimal-change nephrotic syndrome of childhood. Am. J. Dis. Child. 136(8), 713\u2013717  (1982).","DOI":"10.1001\/archpedi.1982.03970440057016"},{"key":"15387_CR7","first-page":"84","volume":"2[4]","author":"HA Madani","year":"2014","unstructured":"Madani, H. A., Bazaraa, H. M. & Rady, H. Association of cytokine genes polymorphisms and the response to corticosteroid therapy in children with idiopathic nephrotic syndrome: A pilot study in Egypt. Int. Res. J. Med. Med. Sci. 2[4], 84\u201390 (2014).","journal-title":"Int. Res. J. Med. Med. Sci."},{"key":"15387_CR8","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.7.3195","author":"AG Wilson","year":"1997","unstructured":"Wilson, A. G., Symons, J. A., McDowell, T. L., McDevitt, H. O. & Duff, G. W. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc. Natl. Acad. Sci. U S A. https:\/\/doi.org\/10.1073\/pnas.94.7.3195 (1997). 94[7]:3195.","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"15387_CR9","doi-asserted-by":"publisher","unstructured":"Shu, K. H., Lee, S. H., Cheng, C. H., Wu, M. J. & Lian, J. D. Impact of interleukin-1 receptor antagonist and tumor necrosis factor-alpha gene polymorphism on IgA nephropathy. Kidney Int. 58(2), 783-9 (2000). https:\/\/doi.org\/10.1046\/j.1523-1755.2000.00227.x.","DOI":"10.1046\/j.1523-1755.2000.00227.x"},{"key":"15387_CR10","doi-asserted-by":"crossref","unstructured":"Li, L. et al. Association of IL-1A and IL-1B polymorphisms with ankylosing spondylitis among the Chinese Han population: A case\u2013control study. Oncotarget  8(17), 28278.11 (2017).","DOI":"10.18632\/oncotarget.16004"},{"key":"15387_CR11","doi-asserted-by":"crossref","unstructured":"Mann, C. L. et al. Interleukin 1 genotypes in multiple sclerosis and relationship to disease severity. J. Neuroimmunol. 129(1\u20132), 197\u2013204   (2002).","DOI":"10.1016\/S0165-5728(02)00181-9"},{"key":"15387_CR12","doi-asserted-by":"crossref","unstructured":"Jan\u010di\u0107, I. et al. Influence of promoter polymorphisms of the TNF-\u03b1 [-308G\/A] and IL-6 [-174G\/C] genes on therapeutic response to etanercept in rheumatoid arthritis. J. Med. Biochem. 34(4), 414  (2015).","DOI":"10.2478\/jomb-2014-0060"},{"issue":"6","key":"15387_CR13","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1111\/j.1365-3083.2011.02602.x","volume":"74","author":"T Qidwai","year":"2011","unstructured":"Qidwai, T. & Khan, F. Tumour necrosis factor gene polymorphism and disease prevalence. Scand. J. Immunol. 74 (6), 522\u2013547 (2011).","journal-title":"Scand. J. Immunol."},{"key":"15387_CR14","first-page":"164168","volume":"12","author":"I Tieranu","year":"2017","unstructured":"Tieranu, I. et al. Preliminary study regarding the association between tumor necrosis factor- alpha gene polymorphisms and childhood idiopathic nephrotic syndrome in Romanian pediatric patients. Maedica [Buchar]. 12, 164168 (2017).","journal-title":"Maedica [Buchar]"},{"issue":"2","key":"15387_CR15","first-page":"95","volume":"1","author":"S Sadeghi-Bojd","year":"2021","unstructured":"Sadeghi-Bojd, S. et al. Lack of association between TNF-alpha rs1800629 [-308 G\u2009>\u2009A] polymorphism and nephrotic syndrome. Iran. J. Kidney Dis. 1 (2), 95 (2021).","journal-title":"Iran. J. Kidney Dis."},{"key":"15387_CR16","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.cyto.2017.06.021","volume":"102","author":"DM Youssef","year":"2018","unstructured":"Youssef, D. M., Amal, S., Hussein, S., Salah, K. & Abd El Rahman, E. A. Tumor necrosis factor alpha gene polymorphisms and haplotypes in Egyptian children with nephrotic syndrome. Cytokine 102, 76\u201382 (2018).","journal-title":"Cytokine"},{"key":"15387_CR17","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1007\/s12291-011-0126-2","volume":"26[3]","author":"T Jafar","year":"2011","unstructured":"Jafar, T. et al. Cytokine gene polymorphism in idiopathic nephrotic syndrome children. Indian J. Clin. Biochem. 26[3], 296\u2013302 (2011).","journal-title":"Indian J. Clin. Biochem."},{"key":"15387_CR18","unstructured":"Midan, D. A., Elhelbawy, N. G., Ahmedy, I. A. & Noreldin, R. I. Cytokine gene polymorphism in children with idiopathic nephrotic syndrome. Iran. J. Kidney Dis.  11(6), 414 (2017)."},{"key":"15387_CR19","doi-asserted-by":"crossref","unstructured":"Page, M. J. et al. The PRISMA 2020 statement: An updated guideline for reporting.","DOI":"10.31222\/osf.io\/v7gm2"},{"issue":"7","key":"15387_CR20","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.3390\/jcm13071888","volume":"13","author":"A Pukaj\u0142o-Marczyk","year":"2024","unstructured":"Pukaj\u0142o-Marczyk, A. & Zwoli\u0144ska, D. The role of TNF-\u03b1 in the pathogenesis of idiopathic nephrotic syndrome and its usefulness as a marker of the disease course. J. Clin. Med. 13 (7), 1888. https:\/\/doi.org\/10.3390\/jcm13071888 (2024). Published 2024 Mar 25.","journal-title":"J. Clin. Med."},{"key":"15387_CR21","unstructured":"Lipska-Zi\u0119tkiewicz, B. S. & Genetic Steroid-resistant nephrotic syndrome overview. Aug 26. In GeneReviews\u00ae [Internet] (Adam, M.P., Feldman, J., Mirzaa, G.M. et al., eds.).  1993\u20132025. (University of Washington,2021).  https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK573219\/"},{"issue":"2","key":"15387_CR22","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3390\/medicina58020265","volume":"58","author":"I Tieranu","year":"2022","unstructured":"Tieranu, I. et al. Genetic variants of Interleukin-4 in Romanian patients with idiopathic nephrotic syndrome. Med. (Kaunas). 58 (2), 265. https:\/\/doi.org\/10.3390\/medicina58020265 (2022). Published 2022 Feb 10.","journal-title":"Med. (Kaunas)"},{"issue":"1","key":"15387_CR23","first-page":"30","volume":"19","author":"A Weissbach","year":"2017","unstructured":"Weissbach, A., Garty, B. Z., Lagovsky, I., Krause, I. & Davidovits, M. Serum tumor necrosis Factor-Alpha levels in children with nephrotic syndrome: A pilot study. Isr. Med. Assoc. J. 19 (1), 30\u201333 (2017). PMID: 28457111.","journal-title":"Isr. Med. Assoc. J."},{"issue":"5","key":"15387_CR24","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.3390\/ijms22052719","volume":"22","author":"DI Jang","year":"2021","unstructured":"Jang, D. I. et al. The role of tumor necrosis factor alpha (TNF-\u03b1) in autoimmune disease and current TNF-\u03b1 inhibitors in therapeutics. Int. J. Mol. Sci. 22 (5), 2719. https:\/\/doi.org\/10.3390\/ijms22052719 (2021). Published 2021 Mar 8.","journal-title":"Int. J. Mol. Sci."},{"key":"15387_CR25","doi-asserted-by":"publisher","unstructured":"Li, G. et al. Serum levels of tumor necrosis factor alpha in patients with IgA nephropathy are closely associated with disease severity. BMC Nephrol. 19(1), 326 (2018). https:\/\/doi.org\/10.1186\/s12882-018-1069-0.","DOI":"10.1186\/s12882-018-1069-0"},{"issue":"11","key":"15387_CR26","doi-asserted-by":"publisher","first-page":"3693","DOI":"10.3390\/jcm14113693","volume":"14","author":"DC Salazar-Camarena","year":"2025","unstructured":"Salazar-Camarena, D. C. et al. Association of TNF-alpha promoter polymorphisms with disease susceptibility, mRNA expression, and lupus nephritis in Mexican patients with systemic lupus erythematosus. J. Clin. Med. 14 (11), 3693. https:\/\/doi.org\/10.3390\/jcm14113693 (2025).","journal-title":"J. Clin. Med."},{"key":"15387_CR27","doi-asserted-by":"publisher","unstructured":"Elahi, M. M., Asotra, K., Matata, B. M. & Mastana, S. S. Tumor necrosis factor alpha \u2013\u2009308 gene locus promoter polymorphism: an analysis of association with health and disease. Biochim. Biophys. Acta. 1792(3), 163\u2009\u2013\u200972. 2009).   https:\/\/doi.org\/10.1016\/j.bbadis.2009.01.007.","DOI":"10.1016\/j.bbadis.2009.01.007"},{"issue":"6","key":"15387_CR28","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1007\/s00467-003-1122-4","volume":"18","author":"A Bakr","year":"2003","unstructured":"Bakr, A. et al. Tumor necrosis factor-alpha production from mononuclear cells in nephrotic syndrome. Pediatr. Nephrol. 18 (6), 516\u2013520. https:\/\/doi.org\/10.1007\/s00467-003-1122-4 (2003). Epub 2003 Apr 18. PMID: 12707837.","journal-title":"Pediatr. Nephrol."}],"updated-by":[{"DOI":"10.1038\/s41598-025-22709-5","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-15387-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-15387-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-15387-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T14:23:40Z","timestamp":1760365420000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-15387-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,14]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["15387"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-15387-w","relation":{"correction":[{"id-type":"doi","id":"10.1038\/s41598-025-22709-5","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,14]]},"assertion":[{"value":"2 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41598-025-22709-5","URL":"https:\/\/doi.org\/10.1038\/s41598-025-22709-5","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"29797"}}